ID   UTA-SF2-2
AC   CVCL_AS03
DR   JCRB; JCRB1493
DR   JCRB; NIHS0693
DR   SKIP; SKIP000693
DR   Wikidata; Q54992198
RX   PubMed=21124894;
CC   Doubling time: 28.2 +- 4.9 hours (PubMed=21124894).
CC   Discontinued: JCRB; NIHS0693; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1493
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
RX   PubMed=21124894; DOI=10.1371/journal.pone.0014099; PMCID=PMC2990711;
RA   Hayashi, Yohei
RA   Chan, Te-Chuan
RA   Warashina, Masaki
RA   Fukuda, Masakazu
RA   Ariizumi, Takashi
RA   Okabayashi, Koji
RA   Takayama, Naoya
RA   Otsu, Makoto
RA   Eto, Koji
RA   Kusuda-Furue, Miho
RA   Michiue, Tatsuo
RA   Ohnuma, Kiyoshi
RA   Nakauchi, Hiromitsu
RA   Asashima, Makoto
RT   "Reduction of N-glycolylneuraminic acid in human induced pluripotent
RT   stem cells generated or cultured under feeder- and serum-free defined
RT   conditions.";
RL   PLoS ONE 5:e14099.1-e14099.11(2010).
//